Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-03-29
2009-02-24
Andres, Janet L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S118000
Reexamination Certificate
active
07495009
ABSTRACT:
Derivatives of imidazopyridine which have a good affinity for certain sub-types of melanocortin receptors, in particular MC4 receptors and are useful for treating pathological states and diseases in which one or more melanocortin receptors are involved and pharmaceutical compositions containing said products.
REFERENCES:
patent: 6350760 (2002-02-01), Bakshi et al.
patent: PCT/US01/17014 (2001-12-01), None
patent: 2002060879 (2002-08-01), None
patent: PCT/USO1/48856 (2002-08-01), None
Vergoni et al., European Journal of Pharmacology (1999), 369(1), 11-15.
Brault Valérie
Plas Pascale
Poitout Lydie
Roubert Pierre
Sackur Carole
Andres Janet L
Muserliar Charles A.
Rahmani Niloofar
Societe de Conseils de Recherches et d'Applications Scientifique
LandOfFree
Imidazopyridine derivatives as melancortin receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyridine derivatives as melancortin receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridine derivatives as melancortin receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4134071